MPL and JAK2 exon 12 mutations in patients with the Budd-Chiari syndrome or extrahepatic portal vein obstruction.

作者信息

Bergamaschi Gaetano M, Primignani Massimo, Barosi Giovanni, Fabris Federica M, Villani Laura, Reati Raffaella, Dell'era Alessandra, Mannucci Pier M

出版信息

Blood. 2008 Apr 15;111(8):4418. doi: 10.1182/blood-2008-02-137687.

DOI:10.1182/blood-2008-02-137687

PMID:18398061

Abstract

摘要

相似文献

MPL and JAK2 exon 12 mutations in patients with the Budd-Chiari syndrome or extrahepatic portal vein obstruction.

Blood. 2008 Apr 15;111(8):4418. doi: 10.1182/blood-2008-02-137687.

Absence of the JAK2 exon 12 mutations in patients with splanchnic venous thrombosis and without overt myeloproliferative neoplasms.

Am J Hematol. 2009 Feb;84(2):126-7. doi: 10.1002/ajh.21335.

Next-generation sequencing in the diagnosis of non-cirrhotic splanchnic vein thrombosis.

J Hepatol. 2021 Jan;74(1):89-95. doi: 10.1016/j.jhep.2020.06.045. Epub 2020 Jul 15.

Occurrence of the JAK2 V617F mutation in the Budd-Chiari syndrome.

Blood Coagul Fibrinolysis. 2008 Jul;19(5):459-62. doi: 10.1097/MBC.0b013e3283049662.

Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment.

Thromb Haemost. 2016 Jan;115(2):240-9. doi: 10.1160/TH15-04-0326. Epub 2015 Sep 3.

MPL mutation profile in JAK2 mutation-negative patients with myeloproliferative disorders.

Diagn Mol Pathol. 2011 Mar;20(1):34-9. doi: 10.1097/PDM.0b013e3181ecd261.

Prevalence of the JAK2 V617F mutation associated with splanchnic vein thrombosis. A 10-year retrospective study.

Thromb Haemost. 2009 Apr;101(4):787-9.

Budd Chiari syndrome and V617F/JAK 2 mutation linked with the myeloproliferative disorders.

J Gastrointestin Liver Dis. 2010 Mar;19(1):108-9.

Increased frequency of co-existing JAK2 exon-12 or MPL exon-10 mutations in patients with low JAK2(V617F) allelic burden.

Leuk Lymphoma. 2016;57(6):1429-35. doi: 10.3109/10428194.2015.1091932. Epub 2015 Dec 23.

JAK2V617F and prothrombin G20210A gene mutations in a patient with Budd-Chiari syndrome and essential thrombocythemia.

Clin Appl Thromb Hemost. 2010 Aug;16(4):472-4. doi: 10.1177/1076029609332110. Epub 2009 Feb 16.

引用本文的文献

Pathological and genomic features of myeloproliferative neoplasms associated with splanchnic vein thrombosis in a single-center cohort.

Ann Hematol. 2023 Jun;102(6):1409-1420. doi: 10.1007/s00277-023-05217-2. Epub 2023 Apr 20.

Detection of Mutations Using High Resolution Melting Curve Analysis (HRM-A); Application on a Large Cohort of Greek ET and MF Patients.

Mediterr J Hematol Infect Dis. 2019 Jan 1;11(1):e2019009. doi: 10.4084/MJHID.2019.009. eCollection 2019.

Detecting Mutations in Splanchnic Vein Thrombosis: Who and How?

J Transl Int Med. 2018 Jun 26;6(2):55-57. doi: 10.2478/jtim-2018-0015. eCollection 2018 Jun.

Splanchnic vein thrombosis in myeloproliferative neoplasms: pathophysiology and molecular mechanisms of disease.

Ther Adv Hematol. 2017 Mar;8(3):107-118. doi: 10.1177/2040620716680333. Epub 2016 Dec 8.

JAK2 V617F, MPL, and CALR mutations in essential thrombocythaemia and major thrombotic complications: a single-institute retrospective analysis.

Pathol Oncol Res. 2015 Jul;21(3):751-8. doi: 10.1007/s12253-014-9885-4. Epub 2015 Jan 10.

Distinct clinical characteristics of myeloproliferative neoplasms with calreticulin mutations.

Haematologica. 2014 Jul;99(7):1184-90. doi: 10.3324/haematol.2014.107482. Epub 2014 Jun 3.

Expression of adhesion factor CD239 in bone marrow cells in chronic myeloproliferative diseases.

J Thromb Thrombolysis. 2009 Oct;28(3):299-303. doi: 10.1007/s11239-008-0285-z. Epub 2008 Oct 30.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验